LXRX logo

LXRX
Lexicon Pharmaceuticals Inc

13,611
Mkt Cap
$677.89M
Volume
347,065.00
52W High
$1.95
52W Low
$0.5137
PE Ratio
-11.53
LXRX Fundamentals
Price
$1.58
Prev Close
$1.60
Open
$1.61
50D MA
$1.65
Beta
1.66
Avg. Volume
1.9M
EPS (Annual)
-$0.1387
P/B
5.41
Rev/Employee
$614,851.85
$383.52
Loading...
Loading...
News
all
press releases
Lexicon Pharmaceuticals (NASDAQ:LXRX) Shares Cross Above 200-Day Moving Average - Here's What Happened
Lexicon Pharmaceuticals (NASDAQ:LXRX) Stock Price Passes Above 200-Day Moving Average - Here's What Happened...
MarketBeat·3d ago
News Placeholder
More News
News Placeholder
Lexicon Pharmaceuticals (LXRX) to Release Earnings on Thursday
Lexicon Pharmaceuticals (NASDAQ:LXRX) will be releasing its Q1 2026 earnings before the market opens on Thursday, May 7. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2026-5-7-lexicon-pharmaceuticals-inc-stock...
MarketBeat·3d ago
News Placeholder
Lexicon Pharmaceuticals (NASDAQ:LXRX) Reaches New 1-Year High - Here's Why
Lexicon Pharmaceuticals (NASDAQ:LXRX) Reaches New 52-Week High - What's Next...
MarketBeat·19d ago
News Placeholder
Lexicon Pharmaceuticals (NASDAQ:LXRX) Reaches New 52-Week High - Should You Buy?
Lexicon Pharmaceuticals (NASDAQ:LXRX) Reaches New 52-Week High - Still a Buy...
MarketBeat·25d ago
News Placeholder
Lexicon Pharmaceuticals (NASDAQ:LXRX) Trading 6.3% Higher - Still a Buy?
Lexicon Pharmaceuticals (NASDAQ:LXRX) Trading Up 6.3% - Here's What Happened...
MarketBeat·26d ago
News Placeholder
Lexicon Pharmaceuticals (NASDAQ:LXRX) Stock Passes Above Two Hundred Day Moving Average - What's Next?
Lexicon Pharmaceuticals (NASDAQ:LXRX) Shares Pass Above 200 Day Moving Average - Here's What Happened...
MarketBeat·26d ago
News Placeholder
Lexicon Pharmaceuticals (NASDAQ:LXRX) Trading 8.7% Higher - Time to Buy?
Lexicon Pharmaceuticals (NASDAQ:LXRX) Trading 8.7% Higher - Should You Buy...
MarketBeat·1mo ago
News Placeholder
Lexicon Pharmaceuticals (NASDAQ:LXRX) Stock Passes Above Two Hundred Day Moving Average - Here's Why
Lexicon Pharmaceuticals (NASDAQ:LXRX) Share Price Passes Above 200 Day Moving Average - Should You Sell...
MarketBeat·1mo ago
News Placeholder
LXRX Stock Up as NVO Initiates Phase I Study of Partnered Obesity Drug
Lexicon Pharmaceuticals stock jumps as NVO launches phase I study of oral obesity candidate LX9851, advancing a promising partnered therapy.
Zacks·1mo ago
News Placeholder
Lexicon Pharmaceuticals' (LXRX) Buy Rating Reaffirmed at HC Wainwright
HC Wainwright restated a "buy" rating and issued a $6.00 price objective on shares of Lexicon Pharmaceuticals in a report on Monday...
MarketBeat·1mo ago
<
1
2
...
>

Latest LXRX News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.